Case File
efta-efta00766243DOJ Data Set 9OtherDS9 Document EFTA00766243
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00766243
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: "Je vacation" <jeevacation®gmail.com>
Subject: Re: Fw: Air Ghislaine Amendment
Date: Mon, 11 Jan 2010 19:47:12 +0000
Importance: Normal
You are correct, but not world wide, only if an operator located else where is willing to participate in a flight
demo or charter,
I just spoke to Chris, he is amending the contract, AAG in London also is included, they just acquired that base
last year.
Sent from my BlackBerry® wireless handheld
From: Jeffrey Epstein <[email protected]>
Date: Mon, II Jan 2010 13:52:17 -0500
To:
Cc: Darren Indyk
Subject: Re: Fw: Air Ghislaine Amendment
1 thought the charter was for anywhere.. not only new york
On Mon, Jan 11, 2010 at 1:47 PM, <Illa>
wrote:
I am doing Bell 407 blade tracking test flights now, I have not read this attachment,
Larry
Sent from my BlackBerry® wireless handheld
From: "Shurkus, Christopher R SIK" <
Date: Mon, 11 Jan 2010 13:05:25 -0500
To: a;
DKIESQ<
Subject: Air Ghislaine Amendment
Attached is the contract amendment which documents the requested changes to your new S-76 C-HF. This
amendment adds and deletes the items requested by your team during our configuration meeting in October.
Please print out two copies of this file, sign both and forward to me by express mail. I will have both
countersign and one original sent to your office for file.
Please call me if you have any questions,
Thank you,
Chris Shurkus
EFTA00766243
S-76 Program Manager
Sikorsky Aircraft Corp.
Phone:
Efax:
Cell:
Email:
6900 Main Street
Mail Stop S358A
Stratford, CT 06615
The Information In this transmission is privileged and confidential and is meant to be read and wed only by the Intended recipient. If you how received this transmission in mon
please notify me immediately by telephone or e-mail and delete the original message and all attachments. Any trek% we. dthemlnatton. distribution or copying of this
transmittal by art unintended recipient is strictly prohibited, and may be a Wolatlon of labsubject to penalty.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments.
EFTA00766244
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.